Publications by authors named "Robin Reschke"

Claim this Profile
O
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients.
Selma Ugurel, Nessr Abu Rached, Thilo Gambichler, Miriam Mengoni, Thomas Tüting, Robin Reschke

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities.
Robin Reschke, Alexander H Enk, Jessica C Hassel

Signal Transduct Target Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Biomarkers in Evolving Melanoma Immunotherapy.
Robin Reschke, Alexander H Enk, Jessica C Hassel

Am J Clin Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin Syndrome.
Robin Reschke, Jasmin Richter, Alexander H Enk, Jessica C Hassel

JAMA Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting molecular pathways to control immune checkpoint inhibitor toxicities.
Robin Reschke, Ryan J Sullivan, Evan J Lipson, Alexander H Enk, Thomas F Gajewski

Trends Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC).
Ahmed M Mousa, Alexander H Enk, Jessica C Hassel, Robin Reschke

Cells· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous Melanoma.
Robin Reschke, Alexander H Enk, Jessica C Hassel

Pharmaceutics· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets.
Robin Reschke, Alexander H Enk, Jessica C Hassel

Int J Mol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?
Robin Reschke, Benjamin Deitert, Alex H Enk, Jessica C Hassel

Front Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. 2022, , 2458.
Robin Reschke, Daniel J Olson

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Value of Dual-Energy CT-Derived Metrics for the Use of Bone Substitutes in Distal Radius Fracture Surgery.
Philipp Reschke, Vitali Koch, Scherwin Mahmoudi, Christian Booz, Ibrahim Yel, Robin Reschke

Diagnostics (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands.
Felix Johnson, Benedikt Hofauer, Markus Wirth, Barbara Wollenberg, Fabian Stögbauer, Robin Reschke

Cancers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors.
Julia-Christina Stadler, Laura Keller, Christian Mess, Alexander T Bauer, Julian Koett, Robin Reschke

J Immunother Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-resident memory T cells in immune-related adverse events: friend or foe?
Robin Reschke, Thomas F Gajewski

Oncoimmunology· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines.
Robin Reschke, Jason W Shapiro, Jovian Yu, Sherin J Rouhani, Daniel J Olson

Cancer Immunol Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome.
Robin Reschke, Stephanie Zimmerlich, Christine Döhring, Gerhard Behre, Mirjana Ziemer

Biomedicines· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL9 and CXCL10 bring the heat to tumors.
Robin Reschke, Thomas F Gajewski

Sci Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gummatous Cutaneous Syphilis.
Robin Reschke, Manfred Kunz, Mirjana Ziemer

Dtsch Arztebl Int· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy.
Robin Reschke, Daniel J Olson

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Stratification and Clinical Characteristics of Patients with Late Recurrence of Melanoma (>10 Years).
Robin Reschke, Konstantin Dumann, Mirjana Ziemer

J Clin Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe COVID-19 infection is associated with aberrant cytokine production by infected lung epithelial cells rather than by systemic immune dysfunction.
Sherin J Rouhani, Jonathan A Trujillo, Athalia R Pyzer, Jovian Yu, Jessica Fessler, Robin Reschke

Res Sq· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma.
Robin Reschke, Jovian Yu, Blake Flood, Emily F Higgs, Ken Hatogai

J Immunother Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy.
Robin Reschke, Philipp Gussek, Andreas Boldt, Ulrich Sack, Ulrike Köhl

Int J Mol Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erosive Pustular Dermatosis of the Scalp: Clinicopathological Correlation Leading to a Definition of Diagnostic Criteria.
Robin Reschke, Sonja Grunewald, Uwe Paasch, Marco Averbeck, Jan C Simon

Wounds· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying High-Risk Tumors within AJCC Stage IB-III Melanomas Using a Seven-Marker Immunohistochemical Signature.
Robin Reschke, Philipp Gussek, Mirjana Ziemer

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis